A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Public ClinicalTrials.gov record NCT01706536. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blind, placebo-controlled, parallel arm study. The study population will consist of subjects, 35 to 75 years of age, with a diagnosis of moderate to severe COPD per Global Initiative for Chronic Obstructive Lung Disease guidelines.
Study identification
- NCT ID
- NCT01706536
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 275 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- EP-101 12.5 mcg Drug
- EP-101 25 mcg Drug
- EP-101 50 mcg Drug
- EP-101 100 mcg Drug
Drug
Eligibility (public fields only)
- Age range
- 35 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2012 (Type not available)
- Primary completion
- Apr 2013 (Actual)
- Completion
- Apr 2013 (Actual)
- Last update posted
- Mar 8, 2018
2012 – 2013
United States locations
- U.S. sites
- 26
- U.S. states
- 13
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Jasper Summit Research, LLC | Jasper | Alabama | 35501 | — |
| Pulmonary Associates, PA | Phoenix | Arizona | 85006 | — |
| California Research Medical Group, Inc. | Fullerton | California | 92835 | — |
| UCLA David Geffen School of Medicine | Los Angeles | California | 90095 | — |
| Integrated Research Group | Riverside | California | 92506 | — |
| Capital Allergy & Respiratory Disease Center | Sacramento | California | 95819 | — |
| Institute of HealthCare Assessment, Inc. | San Diego | California | 92120 | — |
| Clinical Research of West Florida | Clearwater | Florida | 33765 | — |
| Clinical Research of West Florida | Tampa | Florida | 33603 | — |
| Georgia Clinical Research | Austell | Georgia | 30106 | — |
| Gwinnett Biomedical Research | Lawrenceville | Georgia | 30046 | — |
| Veritas Clinical Specialities, LTD | Topeka | Kansas | 66606 | — |
| Minnesota Lung Center | Minneapolis | Minnesota | 55407 | — |
| American Health Research | Charlotte | North Carolina | 28207 | — |
| North Carolina Clinical Research | Raleigh | North Carolina | 27607 | — |
| New Horizons Clinical Research | Cincinnati | Ohio | 45242 | — |
| Clinical Research Institute of Southern Oregon, PC | Medford | Oregon | 97504 | — |
| Sunstone Medical Research LLC | Medford | Oregon | 97504 | — |
| Allergy Associates Research Center | Portland | Oregon | 97202 | — |
| Greenville Pharmaceutical Research, Inc | Greenville | South Carolina | 29615 | — |
| Upstate Pharmaceutical Research | Greenville | South Carolina | 29615 | — |
| South Carolina Pharmaceutical Research | Spartanburg | South Carolina | 29303 | — |
| CU Pharmacuetical Research | Union | South Carolina | 29379 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Central Texas Health Research | New Braunfels | Texas | 78130 | — |
| Pulmonary Associates of Richmond, Inc. | Richmond | Virginia | 23225 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01706536, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 8, 2018 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01706536 live on ClinicalTrials.gov.